Zhejiang Doer Biologics Co., Ltd.
Clinical trials sponsored by Zhejiang Doer Biologics Co., Ltd., explained in plain language.
-
Weekly shot aims to tame dangerous fat levels in the blood
Disease control Not yet recruitingThis Phase 3 trial tests an investigational biologic called DR10624, given as a weekly injection, in adults with severe hypertriglyceridemia (very high blood fats) who are already on standard lipid-lowering therapy. The study compares two doses of DR10624 against a placebo to see…
Phase: PHASE3 • Sponsor: Zhejiang Doer Biologics Co., Ltd. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New biologic aims to tackle stubborn high triglycerides
Disease control Not yet recruitingThis phase 3 trial tests an investigational injectable drug called DR10624 in adults with severe hypertriglyceridemia (very high blood fats) that remains high despite standard treatment. Participants continue their usual omega-3 therapy and receive weekly injections of DR10624 or…
Phase: PHASE3 • Sponsor: Zhejiang Doer Biologics Co., Ltd. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC